With President Donald Trump “hired” by the American people for a second term, Amazon — which now owns production rights to NBC’s “The…
Gilead Sciences (NASDAQ:GILD) will acquire cancer immunotherapy partner Arcellx (NASDAQ:ACLX) in a deal worth up to US$7.8 billion, moving to take full control…
